Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Rituxan (rituximab) - Biogen, Zenyaku Holdings, Roche
Saphnelo (anifrolumab) - AstraZeneca
Treatment of systemic lupus erythematosus: new therapeutic options. (PubMed, Rev Clin Esp (Barc)) - Nov 25, 2023 - "Biological therapy in lupus, unlike other entities, although it has not been fully established, in recent years it has burst onto the scene with important therapeutic novelties. This review aims to update the therapeutic tools for the treatment of SLE focusing on the new molecules that have achieved the objectives of their clinical trials." 
Journal • Review • Glomerulonephritis • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/38000622
 
Andrés González-García; Guillermo Ruiz-Irastorza; Ivan Cusacovich
 
Nov 25, 2023
 
Prev Next